A Milestone Moment: FDA Approves Addyi® for Hypoactive Sexual Desire Disorder in Postmenopausal Women
December 17, 2025
Brand Name :
awa, kao, kew, ava pepper, intoxicating pepper, kawa
Synonyms :
kava
Class :
Herbals; Neurology & Psychiatry
Suggested dosing
Prevention, withdrawal of benzodiazepine
70% of standardized extract
Initial dose-Administer 50mg orally every day followed by
Titrate up over a week while tapering the benzodiazepine over two weeks.
Do not exceed 300 mg/day, titrated over a week.
70% of standardized extract: Administer 100mg orally thrice a day
Root tea: Administer one cup orally thrice a day; use 2 to 4 g of root in 150 ml water
Kava lactones-Administer 60 to 120 mg/day orally
Kava-lactones: Administer 180 to 210 mg orally every night at bedtime
70% of standardized extract
Initial dose-Administer 50mg orally every day followed by
Titrate up over a week while tapering the benzodiazepine over two weeks.
Do not exceed 300 mg/day, titrated over a week.
may increase the effects of pharmacodynamic synergism
may increase the effects of pharmacodynamic synergism
may increase the effects of pharmacodynamic synergism
may increase the effects of pharmacodynamic synergism
may increase the effects of pharmacodynamic synergism
may increase the effects by pharmacodynamic synergism
may increase the effects by pharmacodynamic synergism
may increase the effects by pharmacodynamic synergism
kava: they may increase the CNS depressant effect of CNS Depressants
kava: they may increase the CNS depressant effect of CNS Depressants
kava: they may increase the CNS depressant effect of CNS Depressants
kava: they may increase the CNS depressant effect of CNS Depressants
kava: they may increase the CNS depressant effect of CNS Depressants
kava: they may increase the CNS depressant effect of CNS Depressants
kava: they may increase the CNS depressant effect of CNS Depressants
kava: they may increase the CNS depressant effect of CNS Depressants
kava: they may enhance the serum concentration of CYP2D6 Inhibitors
kava: they may enhance the serum concentration of CYP2D6 Inhibitors
kava: they may enhance the serum concentration of CYP2D6 Inhibitors
kava: they may enhance the serum concentration of CYP2D6 Inhibitors
kava: they may enhance the serum concentration of CYP2D6 Inhibitors
Actions and Spectrum:
kava, also known as Piper methysticum, is a plant native to the South Pacific islands. It has been traditionally used for its sedative, anxiolytic (anti-anxiety), and muscle relaxant properties.
Frequency not defined
Dizziness
Enlarged pupils
Headache
Hepatotoxicity
Motor reflex impairment
Allergic skin reactions
Drowsiness
Gastrointestinal upset
Hepatitis (acute)
Liver failure
Black box warning:
None
Contraindications/caution:
Contraindications:
Caution:
Pregnancy consideration: Not safe to use during pregnancy
Lactation: Not safe to use during lactation
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology:
Pharmacokinetics:
N/A
Administration:
Patient information leaflet
Generic Name: kava
Why do we use kava?
kava (Piper methysticum) has been traditionally used in the South Pacific islands for its potential relaxing, anxiolytic (anti-anxiety), and soothing properties.